Comparison of Primary B/NKT Non‐Hodgkin Lymphomas in Nasopharynx, Nasal Cavity, and Paranasal Sinuses
Otolaryngology–Head and Neck Surgery · 2023
DOI: 10.1002/ohn.194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Jiajia Peng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oto-Rhino-Laryngology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Paranasal Sinus Neoplasms, Lymphoma, Non-Hodgkin, Paranasal Sinuses, Nose Neoplasms. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objective
We aimed to compare clinical and survival differences between B‐cell (B‐NHL) and NKT‐cell non‐Hodgkin lymphomas (NKT‐NHL) located in the nasal cavity (NC), nasopharynx, and paranasal sinuses, which are always categorized as one sinonasal type. Study Design Patients diagnosed with primary B‐NHL and NKT‐NHL in the nasal cavity, nasopharynx, and paranasal sinuses from Surveillance, Epidemiology, and End Results (SEER) database were included (1975‐2017).
Setting
Population‐based cohort study.
Methods
We conducted univariate and multivariate Cox regressions and Kaplan‐Meier analysis to examine survival outcomes of B/NKT‐NHL in the nasal cavity, nasopharynx, and paranasal sinuses, respectively.
Results
Overall, most B‐NHL cases originated from the nasopharynx, while the majority of NKT‐NHL cases occurred in the nasal cavity. Notably, the cancer‐special survival (CSS) outcomes improved significantly in all sinonasal B‐NHL cases over time, whereas no such improvement trend was observed in each sinonasal NKT‐NHL type. Additionally, increasing age was linked with an elevated risk of death in B‐NHL, particularly in the nasal cavity (Hazard ratio [HR]: 3.37), rather than in NKT‐NHL. Compared with B‐NHL, the adverse effect of a higher stage on CSS was more evident in NKT‐NHL, particularly in its nasopharynx site (HR: 5.12). Furthermore, radiotherapy was beneficial for survival in patients with sinonasal B‐NHL and NKT‐NHL, except in the nasopharynx NKT‐NHL. However, chemotherapy has only been beneficial for CSS in patients with paranasal sinuses B‐NHL (HR: 0.42) since 2010, rather than in other types of B/NKT‐NHL.
Conclusion
Although B‐NHL and NKT‐NHL in the nasal cavity, nasopharynx and paranasal sinuses have similar anatomical locations, their clinicodemographics and prognoses are largely different and should be treated and studied as distinct diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oto-Rhino-Laryngology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
- Department of Oto-Rhino-Laryngology, West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
- Department of Oto-Rhino-Laryngology, Langzhong People's Hospital, Sichuan, Langzhong, China.
- Department of Oto-Rhino-Laryngology, Suining People's Hospital, Sichuan, Suining, China.
- Department of Biostatistics, Princess Margaret Cancer Centre and Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Zitieren
APA
Peng, J., Qiu, J., Cheng, D., Rao, Y., Mao, M., Qiu, K., Li, J., Chen, F., Liu, F., Liu, J., Mu, X., Yu, W., Zhang, W., Xu, W., Zhao, Y., & Ren, J. (2023). Comparison of Primary B/NKT Non‐Hodgkin Lymphomas in Nasopharynx, Nasal Cavity, and Paranasal Sinuses. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.194
Vancouver
Peng J, Qiu J, Cheng D, Rao Y, Mao M, Qiu K, et al. Comparison of Primary B/NKT Non‐Hodgkin Lymphomas in Nasopharynx, Nasal Cavity, and Paranasal Sinuses. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.194
BibTeX
@article{Peng2023,
author = {Peng, Jiajia and Qiu, Jianqing and Cheng, Danni and Rao, Yufang and Mao, Minzi and Qiu, Ke and Li, Junhong and Chen, Fei and Liu, Feng and Liu, Jun and Mu, Xiaosong and Yu, Wenxin and Zhang, Wei and Xu, Wei and Zhao, Yu and Ren, Jianjun},
title = {Comparison of Primary B/NKT Non‐Hodgkin Lymphomas in Nasopharynx, Nasal Cavity, and Paranasal Sinuses},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
doi = {10.1002/ohn.194}
}
EUVIMED